Stuelpnagel John Rinsider trades

In SEC Form 4 filings, Stuelpnagel John R is listed as Director of 10x Genomics, Inc. (TXG). In the last 90 days, Stuelpnagel John R sold $1.24M of 10x Genomics, Inc. (TXG) on the open market and bought none.

Companies and roles

Company	Role	Transactions	Last filed
TXG10x Genomics, Inc.	Director	3	Sep 8

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-08

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
TXG10x Genomics, Inc.	Sep 3	Sep 8	S	7,012	$60.66	Sale −$425,333	341,424	No	Form 4
TXG10x Genomics, Inc.	Sep 3	Sep 8	S	6,814	$62.11	Sale −$423,205	334,610	No	Form 4
TXG10x Genomics, Inc.	Sep 3	Sep 8	S	6,174	$62.61	Sale −$386,533	328,436	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.